Eyegate Pharmaceuticals CFO resigns
Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Ryan Brenneman is no longer Eyegate Pharmaceuticals Inc.'s CFO and principal financial and accounting officer.
Brenneman resigned from the positions, prompting company President and CEO Stephen From to assume the role of principal financial and accounting officer.
